4//SEC Filing
BERGER FRANKLIN M 4
Accession 0000950170-24-135930
CIK 0001593899other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 6:00 PM ET
Size
4.9 KB
Accession
0000950170-24-135930
Insider Transaction Report
Form 4
BERGER FRANKLIN M
Director
Transactions
- Sale
Common Stock
2024-12-10$2.85/sh−359,606$1,023,475→ 451,897 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.75 to $2.955. The Reporting Person undertakes to provide Atea Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Atea Pharmaceuticals, Inc.
CIK 0001593899
Entity typeother
Related Parties
1- filerCIK 0001273885
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 6:00 PM ET
- Size
- 4.9 KB